blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0060668

EP0060668 - N-carboxyalkyl dipeptide derivatives and pharmaceutical compositions thereof [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  05.08.1986
Database last updated on 24.07.2024
Most recent event   Tooltip05.08.1986No opposition filed within time limitpublished on 24.09.1986 [1986/39]
Applicant(s)For all designated states
BEECHAM GROUP PLC
Beecham House, Great West Road Brentford
Middlesex TW8 9BD / GB
[N/P]
Former [1982/38]For all designated states
BEECHAM GROUP PLC
Beecham House Great West Road
Brentford Middlesex TW8 9BD / GB
Inventor(s)01 / Markwell, Roger Edward
22 Vemore Drive
Great Dunmow Essex / GB
[1982/38]
Representative(s)Stott, Michael John, et al
European Patent Attorney Beecham Pharmaceuticals Great Burgh Yew Tree Bottom Road
Epsom, Surrey KT18 5XQ / GB
[N/P]
Former [1982/38]Stott, Michael John, et al
European Patent Attorney Beecham Pharmaceuticals Great Burgh Yew Tree Bottom Road
Epsom Surrey KT18 5XQ / GB
Application number, filing date82301184.608.03.1982
[1982/38]
Priority number, dateGB1981000783712.03.1981         Original published format: GB 8107837
[1982/38]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP0060668
Date:22.09.1982
Language:EN
[1982/38]
Type: B1 Patent specification 
No.:EP0060668
Date:09.10.1985
Language:EN
[1985/41]
Search report(s)(Supplementary) European search report - dispatched on:EP07.07.1982
ClassificationIPC:C07K5/06, A61K37/02
[1985/41]
CPC:
A61P43/00 (EP); A61P9/12 (EP); C07D307/79 (EP,US);
C07D307/80 (EP,US); C07K5/0222 (EP,US); A61K38/00 (EP,US)
Former IPC [1982/38]C07C103/52, A61K37/02
Designated contracting statesBE,   CH,   DE,   FR,   GB,   IT,   LI,   NL,   SE [1982/38]
TitleGerman:N-Carboxyalkyl-dipeptid-Derivate und deren Arzneimittel[1982/38]
English:N-carboxyalkyl dipeptide derivatives and pharmaceutical compositions thereof[1982/38]
French:Dérivés N-carboxyalcoyldipeptidiques et leurs compositions pharmaceutiques[1982/38]
Examination procedure18.10.1982Examination requested  [1982/52]
22.03.1983Despatch of a communication from the examining division (Time limit: M04)
24.06.1983Reply to a communication from the examining division
01.02.1984Despatch of a communication from the examining division (Time limit: M04)
16.05.1984Reply to a communication from the examining division
04.12.1984Despatch of communication of intention to grant (Approval: )
26.02.1985Communication of intention to grant the patent
12.03.1985Fee for grant paid
12.03.1985Fee for publishing/printing paid
Opposition(s)10.07.1986No opposition filed within time limit [1986/39]
Fees paidRenewal fee
14.03.1984Renewal fee patent year 03
13.03.1985Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:SearchFR2407204  [ ] (SANDOZ SA [CH])
    [ ] - TETRAHEDRON LETTERS, Vol. 22, No. 26, 26th issue, July 1981, Pergamon Press Ltd. (GB) D.G. HANGAUER: "A one-step Synthesis of Ethyl 4 - beta-Indolyl) -2- Ketobutyrate via Polyanion Chemistry and its Conversion into Angiotensin Converting Enzyme Inhibitors", pages 2439-2442
    [ ] - NATURE, Vol. 288, November 20, 1980, MacMillan Journals Ltd. A.A. PATCHETT et al.: "A New Class of Angiotensin-Converting Enzyme Inhibitors", pages 280-283
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.